{"id":"W2789877692","doi":"10.1200/jco.2018.36.6_suppl.225","title":"Cabozantinib for metastatic castration-resistant prostate cancer (mCRPC) following docetaxel: Combined analysis of two phase III trials.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Docetaxel; Cabozantinib; Oncology; Internal medicine; Prostate cancer; Hazard ratio; Proportional hazards model; Enzalutamide; Cancer; Confidence interval; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01314752,0.001390578,0.005071145,0.001476637,0.0002890275,0.002031788,0.0006777243,0.0008548066,0.001465266],"category_scores_gemma":[0.008268951,0.0006258112,0.007307294,0.002076547,0.0004651694,0.0008182489,0.0006715792,0.001205323,0.0003199619],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001072336,"about_ca_system_score_gemma":0.001852197,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009189669,"about_ca_topic_score_gemma":0.004168645,"domain_scores_codex":[0.9942101,0.004047697,0.0004276568,0.0004452002,0.0005812006,0.0002881705],"domain_scores_gemma":[0.9946094,0.00227397,0.001774179,0.000501434,0.000332202,0.0005087954],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.6896462,0.002931717,0.06802244,0.00674102,0.0885243,0.0002829108,0.0001253192,0.0038506,0.005654892,0.0002175487,0.003071291,0.1309317],"study_design_scores_gemma":[0.3826182,0.1708726,0.2434801,0.0009133331,0.1742553,0.001148338,0.0001710954,0.007457081,0.003171664,0.00089635,0.01483357,0.0001823267],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8637286,0.1173012,0.003099295,0.001101574,0.0003523422,0.004331299,0.007468776,0.0002815124,0.002335204],"genre_scores_gemma":[0.9724525,0.01521372,0.002902255,0.0004567818,0.0002192525,0.001730239,0.006020379,0.00004695155,0.0009579298],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01314752,"threshold_uncertainty_score":0.06953156,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3196519608841015,"score_gpt":0.6077363090943942,"score_spread":0.2880843482102927,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}